Search

Your search keyword '"Gunson, Rory"' showing total 63 results

Search Constraints

Start Over You searched for: Author "Gunson, Rory" Remove constraint Author: "Gunson, Rory" Publisher elsevier bv Remove constraint Publisher: elsevier bv
63 results on '"Gunson, Rory"'

Search Results

1. Swab pooling enables rapid expansion of high-throughput capacity for SARS-CoV-2 community testing

2. Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent

3. Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent

4. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

5. Corrigendum to ‘Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs’ [J Hepatol 76 (2022) 549–557]

6. Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study

7. Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs

8. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018–2019

9. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

10. The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland

11. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface

12. Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak

13. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

14. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

15. High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs

20. Multicenter clinical comparative evaluation of Alinity m HIV-1 assay performance

22. Multicenter clinical evaluation of alinity m HBV assay performance

23. Multicenter clinical evaluation of alinity m HCV assay performance

24. Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs

25. End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19

26. Evaluating the Effectiveness of Influenza Vaccine in People With At-Risk Medical Conditions: A Test-Negative Design Case-Control Study for the Seasonal Influenza Vaccine Effectiveness II (SIVE II) Project

27. Increased risk of HIV and other drug-related harms associated with injecting in public places among people who inject drugs in Scotland: a national bio-behavioural survey

28. Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

29. Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers

31. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis

34. Seasonal Influenza Vaccine Effectiveness for the Prevention of Laboratory-Confirmed Influenza in Asthma During the Influenza Seasons 2010-11 to 2015-16 in Scotland: A National Test-Negative Design Case-Control Study

35. Erratum to “Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18” [Vaccine 35 (2017) 4828–4835]

41. Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

Catalog

Books, media, physical & digital resources